0001628280-24-030630.txt : 20240701 0001628280-24-030630.hdr.sgml : 20240701 20240701160520 ACCESSION NUMBER: 0001628280-24-030630 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240701 DATE AS OF CHANGE: 20240701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rackliffe Philip CENTRAL INDEX KEY: 0002027284 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 241090518 MAIL ADDRESS: STREET 1: 500 W. MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 3 1 wk-form3_1719864308.xml FORM 3 X0206 3 2024-07-01 0 0001932393 GE HealthCare Technologies Inc. GEHC 0002027284 Rackliffe Philip 500 W. MONROE STREET CHICAGO IL 60661 0 1 0 0 CEO, Ultrasound & IGT Common Stock, par value $0.01 per share 13117 D Employee Stock Option (right to buy) 70.01 2033-02-01 Common Stock, par value $0.01 per share 7838 D Employee Stock Option (right to buy) 75.30 2033-03-01 Common Stock, par value $0.01 per share 4631 D Employee Stock Option (right to buy) 92.72 2034-03-01 Common Stock, par value $0.01 per share 3834 D Consists of awards of: (i) 9,217 restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, granted on September 1, 2022, of which 50% will vest on September 1, 2024 and 50% will vest on September 1, 2025; (ii) 892 restricted stock units with respect to GE HealthCare common stock, granted on February 1, 2023, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026; (iii) 1,660 restricted stock units with respect to GE HealthCare common stock, granted on March 1, 2023, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026; and (iv) 1,348 restricted stock units with respect to GE HealthCare common stock, granted on March 1, 2024, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027. Exhibit 24.1 - Power of Attorney /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact 2024-07-01 EX-24.1 2 powerofattorneyrackliffe.htm EX-24.1 Document

Power of Attorney
KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each of (i) Frank R. Jimenez and (ii) Jenny L. Lauth, signing SINGLY, the undersigned’s true and lawful attorney-in-fact to:
(1)     execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director or holder of ten percent (10%) or more of the registered class of securities of GE HealthCare Technologies Inc. (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;
(2)    If necessary, submit a Form ID to apply for and obtain EDGAR filing codes in order to file a Form 3 on behalf of the undersigned;
(3)     do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto and timely file such forms or amendments with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(4)     take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
* * * * *




IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12th day of June 2024.


By: /s/ Philip Rackliffe_____
    Name: Philip Rackliffe
    

[Signature Page to Power of Attorney (Forms 3, 4 & 5)]